Characterisation of naturally occurring MERS-CoV Spike mutations and their impact on entry and neutralisation.

1. Problem Statement

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) remains a significant public health threat with pandemic potential due to frequent zoonotic spillovers from dromedary camels and documented human-to-human transmission. Since its emergence in 2012, the virus has evolved, with Clade B (specifically Lineage 5) becoming the dominant circulating strain in the Middle East, outcompeting the original Clade A reference strain (EMC/2012).

The Spike (S) protein is the primary determinant of viral entry and the main target for neutralizing antibodies. However, the phenotypic consequences of naturally occurring single nucleotide polymorphisms (SNPs) in contemporary MERS-CoV strains are poorly understood. There is a critical knowledge gap regarding whether these mutations:

• Enhance viral entry (increasing infectivity).
• Confer partial immune escape (reducing neutralization by antibodies from previously infected individuals).
• Interact synergistically with the genetic background of the circulating Lineage 5 viruses (as opposed to the older EMC/2012 backbone used in most prior studies).

2. Methodology

The study employed a lentiviral pseudotyping system to safely characterize 15 specific Spike mutations without handling live MERS-CoV.

• Sequence Analysis: Researchers aligned 584 MERS-CoV Spike sequences from human clinical isolates (2012–2024) and passaged viruses. They identified 27 SNPs and selected 15 for characterization based on frequency, location (NTD, RBD, or near S1/S2 cleavage site), and potential functional impact.
• Backbone Selection: A Clade B, Lineage 5 wildtype Spike sequence (derived from a 2019 Saudi Arabian clinical isolate) was used as the backbone. This is a crucial distinction from previous studies that used the EMC/2012 (Clade A) backbone.
• Mutagenesis: Site-directed mutagenesis was used to introduce the 15 selected mutations individually into the wildtype backbone.
• Pseudotype Generation: Lentiviral particles (p8.91 packaging + pCSFLW luciferase reporter) were pseudotyped with the various Spike variants in HEK-293T cells.
• Functional Assays:
  • Titration: Luciferase-based infectivity assays on HEK-293T cells expressing human DPP4 to measure viral entry efficiency.
  • Cell-Cell Fusion: A split-GFP assay co-culturing Spike-expressing HEK-293T cells with DPP4-expressing BHK-21 cells to visualize and quantify receptor binding and membrane fusion (syncytia formation) over 24 hours.
  • Microneutralization: Pseudotypes were incubated with pooled patient sera (from the 1st WHO International Standard for Anti-MERS-CoV IgG, derived from South Korean 2015 outbreak survivors) to determine resistance to neutralization (IC50 values).

3. Key Contributions

• Contextual Relevance: The study is the first to characterize these specific mutations using a contemporary Lineage 5 backbone, addressing the limitation of previous research relying on the outdated EMC/2012 strain.
• Phenotypic Mapping: It provides a comprehensive map of how specific naturally occurring SNPs affect three critical viral functions: entry efficiency, receptor binding/fusion, and immune evasion.
• Identification of Dual-Function Mutants: The study identified specific mutations (e.g., L745F) that simultaneously improve viral entry and increase resistance to neutralization, highlighting a potential "worst-case" evolutionary trajectory.

4. Key Results

A. Impact on Viral Entry and Fusion

• Improved Entry: Three mutations significantly enhanced receptor binding and membrane fusion compared to the wildtype:
  • I529T (RBD)
  • E536K (RBD)
  • L745F (Adjacent to S1/S2 cleavage site)
  • Note: I529T had previously been reported to reduce entry in some contexts, but this study found it improved entry in the Lineage 5 background, likely due to compensatory mutations or higher DPP4 expression in the assay system.
• Reduced Entry: Six mutations significantly reduced entry/fusion:
  • T387P, L411F, T424I, W553R, T560I (all in RBD)
  • G94R (in NTD)
  • Note: The reduction in G94R titre was also observed in the initial titration assay, suggesting impaired attachment.
• Neutral Effect: Mutations F473S, L506F, T746K, Q98R, and Q304R showed entry properties comparable to the wildtype.

B. Impact on Neutralization (Immune Escape)

Using pooled sera from recovered patients (Lineage 5 exposure), the study found that five mutations conferred increased resistance to neutralization (higher IC50):

• L411F (RBD)

• T424I (RBD)

• L506F (RBD)

• L745F (S1/S2 adjacent)

• T746K (S1/S2 adjacent)

• G94R (NTD) was notably more sensitive to neutralization than the wildtype.

• The remaining mutations showed neutralization sensitivity comparable to the wildtype.

C. Discrepancies with Previous Literature

The study highlights that mutation effects are backbone-dependent. For example:

• L411F: Previously shown to have no effect on entry in an EMC/2012 backbone; here, it reduced entry in the Lineage 5 backbone.
• I529T: Previously associated with reduced neutralization against early sera; here, it showed no significant change in neutralization against Lineage 5 sera, likely because the sera donors were infected with strains already carrying I529T.

5. Significance and Implications

• Public Health Risk: The identification of mutations like L745F is particularly concerning as it confers a "double advantage": it improves viral entry (increasing infectivity) and reduces neutralization by existing immunity. This suggests MERS-CoV could evolve to become more transmissible and harder to control via natural immunity or vaccines.
• Surveillance Utility: The developed pseudotyping system serves as a rapid, high-throughput tool for monitoring emerging MERS-CoV variants. It allows researchers to assess the functional impact of new mutations before they become widespread.
• Countermeasure Development: Understanding which epitopes are vulnerable (e.g., NTD mutations like G94R increasing sensitivity) versus those that facilitate escape (RBD and S1/S2 mutations) is critical for designing next-generation vaccines and monoclonal antibody therapies that target conserved, essential regions of the Spike protein.
• Evolutionary Insight: The results underscore that the genetic background (Lineage 5 vs. Clade A) significantly alters the phenotypic outcome of mutations, emphasizing the need for continuous surveillance of circulating strains rather than relying solely on historical reference strains.